Company CARGO Therapeutics, Inc.

Equities

CRGX

US14179K1016

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 14/06/2024 BST 5-day change 1st Jan Change
16.72 USD -2.68% Intraday chart for CARGO Therapeutics, Inc. -6.90% -27.78%

Business Summary

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in advancing curative cell therapies for cancer patients. Its programs, platform technologies, and manufacturing strategy are designed to directly address the chimeric antigen receptor (CAR) T-cell therapies. The CAR is a protein that has been engineered to modify T cells so they can recognize and destroy cancer cells. The Company’s lead program, firicabtagene autoleucel (CRG-022), is an autologous (derived from a patient’s cells) CD22 CAR T-cell product candidate. The Company is also engaged in evaluating CRG-022 in patients at earlier stages of disease, including large B-cell lymphoma (LBCL) and other hematologic malignancies. The Company is also leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic designed by the Company to enhance CAR T-cell persistence and trafficking to tumor lesions.

Number of employees: 123

Managers

Managers TitleAgeSince
Chief Executive Officer 57 30/04/22
Director of Finance/CFO 44 31/07/22
Chief Tech/Sci/R&D Officer 43 31/07/23
Chief Tech/Sci/R&D Officer 56 31/12/21
Chief Tech/Sci/R&D Officer 59 16/10/23
Chief Tech/Sci/R&D Officer - 30/06/23
39 -
Human Resources Officer - 30/06/23
General Counsel 54 31/07/23

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 30/06/23
Chairman 59 31/08/22
Chief Executive Officer 57 30/04/22
Director/Board Member 64 04-14
Director/Board Member 52 28/02/23
Director/Board Member 45 30/09/22
Director/Board Member 39 31/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 45,846,963 42,856,735 ( 93.48 %) 0 93.48 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
15.70 %
6,180,771 15.70 % 117 M $
Samsara Biocapital LLC
11.21 %
4,415,689 11.21 % 84 M $
RTW Investments LP
9.487 %
3,735,619 9.487 % 71 M $
Perceptive Advisors LLC
8.757 %
3,448,004 8.757 % 66 M $
T. Rowe Price International Ltd.
7.856 %
3,093,347 7.856 % 59 M $
Janus Henderson Investors US LLC
6.754 %
2,659,580 6.754 % 51 M $
Nextech Invest AG
6.711 %
2,642,502 6.711 % 50 M $
Red Tree Venture Capital
6.278 %
2,471,973 6.278 % 47 M $
Third Rock Ventures LLC
4.589 %
1,807,119 4.589 % 34 M $
Wellington Management Co. LLP
4.366 %
1,719,211 4.366 % 33 M $

Company contact information

Cargo Therapeutics, Inc.

835 Industrial Road Suite 400

94070, San Carlos

+

http://cargo-tx.com
address CARGO Therapeutics, Inc.(CRGX)
  1. Stock Market
  2. Equities
  3. CRGX Stock
  4. Company CARGO Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW